Dow Down 3.39% Nasdaq Down 4.12%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
339.48 Down 17.66(4.94%) Jun 24, 4:00PM EDT
|After Hours : 339.00 Down 0.48 (0.14%) Jun 24, 7:53PM EDT
Prev Close:357.14
Open:341.70
Bid:325.01 x 100
Ask:339.48 x 100
1y Target Est:473.48
Beta:1.47897
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:338.69 - 350.09
52wk Range:338.69 - 605.93
Volume:1,288,269
Avg Vol (3m):950,588
Market Cap:35.49B
P/E (ttm):53.83
EPS (ttm):6.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 4.94%35.49B
AMGNDown 3.82%110.02B

Key Statistics

Forward P/E (1 yr):21.89
P/S (ttm):8.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.84
Quarterly EPS Est (Jun-16) :2.62
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback